MedPath

Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)

Not Applicable
Recruiting
Conditions
Low Back Pain
Registration Number
NCT06268522
Lead Sponsor
Brigham and Women's Hospital
Brief Summary

This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Pain InterferenceBaseline, 8 weeks, 3 month and 6 month follow up

assessed by the Brief pain interventory

Opioid DoseBaseline, 8 weeks, 3 month and 6 month follow up

assessed through their medical record

Secondary Outcome Measures
NameTimeMethod
Opioid MisuseBaseline, 8 weeks, 3 month and 6 month follow up

assessed by the Current Opioid Misuse Measure (COMM)

Opioid CravingBaseline,8 weeks, 3 month and 6 month follow up

assessed by the single item Opioid Craving

Opioid WithdrawalBaseline, 8 weeks, 3 month and 6 month follow up

assessed by the Opioid Withdrawal Scale (SOWS)

Pain IntensityBaseline, 8 weeks, 3 month and 6 month follow up

assessed through the Brief Pain Inventory

Trial Locations

Locations (1)

Brigham and Women's Hospital

🇺🇸

Chestnut Hill, Massachusetts, United States

Brigham and Women's Hospital
🇺🇸Chestnut Hill, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.